Search research articles
Contact Us
Filters
Showing results (211-220 of 215) with videos related to
Page
of 22
Sort By:
You have reached the last page of results.
This site can display upto 215 results.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
November 5, 2011
Meningoencephalitis or meningitis in relapsing polychondritis: four case reports and a literature review
Z J Wang, C Q Pu, Z J Wang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 28, 2012
Second-line pemetrexed versus docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer: a randomized, open-label study
Y Sun, Y-L Wu, C-C Zhou, et al.
Cancer Chemotherapy and Pharmacology
|
August 21, 2019
Efficacy and safety of CT-P6 versus reference trastuzumab in HER2-positive early breast cancer: updated results of a randomised phase 3 trial
F J Esteva, Y V Baranau, V Baryash, et al.
The Journal of Headache and Pain
|
February 16, 2018
The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: development, psychometric evaluation and assessment of utility
T J Steiner, D C Buse, M Al Jumah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2008
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial
M Untch, R D Gelber, C Jackisch, et al.
Page
of 22
Search research articles
Search
Showing results (211-220 of 215) with videos related to
Sort By:
Page
of 22
You have reached the last page of results.
This site can display upto 215 results.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
November 5, 2011
Meningoencephalitis or meningitis in relapsing polychondritis: four case reports and a literature review
Z J Wang, C Q Pu, Z J Wang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 28, 2012
Second-line pemetrexed versus docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer: a randomized, open-label study
Y Sun, Y-L Wu, C-C Zhou, et al.
Cancer Chemotherapy and Pharmacology
|
August 21, 2019
Efficacy and safety of CT-P6 versus reference trastuzumab in HER2-positive early breast cancer: updated results of a randomised phase 3 trial
F J Esteva, Y V Baranau, V Baryash, et al.
The Journal of Headache and Pain
|
February 16, 2018
The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: development, psychometric evaluation and assessment of utility
T J Steiner, D C Buse, M Al Jumah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2008
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial
M Untch, R D Gelber, C Jackisch, et al.
Page
of 22